Park Avenue Securities LLC increased its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 860.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 232,282 shares of the company's stock after purchasing an additional 208,092 shares during the period. Park Avenue Securities LLC's holdings in Kenvue were worth $4,959,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in KVUE. Acadian Asset Management LLC acquired a new position in Kenvue during the second quarter worth approximately $412,000. Virtu Financial LLC acquired a new stake in shares of Kenvue during the 2nd quarter worth $1,126,000. Mutual of America Capital Management LLC raised its position in shares of Kenvue by 40.4% in the 2nd quarter. Mutual of America Capital Management LLC now owns 317,504 shares of the company's stock worth $5,772,000 after buying an additional 91,398 shares during the period. Bradley Foster & Sargent Inc. CT boosted its holdings in Kenvue by 13.8% in the second quarter. Bradley Foster & Sargent Inc. CT now owns 280,160 shares of the company's stock valued at $5,093,000 after acquiring an additional 33,968 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. grew its position in Kenvue by 19.3% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 64,465 shares of the company's stock valued at $1,172,000 after acquiring an additional 10,425 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on KVUE. Citigroup decreased their target price on Kenvue from $25.00 to $21.00 and set a "neutral" rating for the company in a report on Wednesday. Deutsche Bank Aktiengesellschaft downgraded Kenvue from a "buy" rating to a "hold" rating and lowered their price target for the company from $25.00 to $24.00 in a report on Thursday, December 12th. Barclays reduced their price objective on Kenvue from $23.00 to $21.00 and set an "equal weight" rating on the stock in a research note on Friday. Jefferies Financial Group assumed coverage on Kenvue in a research note on Tuesday, September 24th. They issued a "buy" rating and a $27.00 target price for the company. Finally, Piper Sandler upgraded Kenvue from a "neutral" rating to an "overweight" rating and raised their target price for the company from $21.00 to $26.00 in a report on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $23.08.
View Our Latest Stock Analysis on Kenvue
Kenvue Stock Down 0.4 %
NYSE KVUE traded down $0.09 during mid-day trading on Friday, reaching $21.11. 11,266,973 shares of the company's stock traded hands, compared to its average volume of 9,329,477. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $24.46. The company has a fifty day simple moving average of $22.42 and a 200-day simple moving average of $21.66. The company has a market cap of $40.46 billion, a price-to-earnings ratio of 38.37, a P/E/G ratio of 1.99 and a beta of 1.46.
Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.01. The business had revenue of $3.90 billion during the quarter, compared to analyst estimates of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The business's revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.31 earnings per share. As a group, equities research analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.
Kenvue Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Stockholders of record on Wednesday, February 12th will be paid a $0.205 dividend. The ex-dividend date is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.89%. Kenvue's dividend payout ratio (DPR) is presently 149.09%.
About Kenvue
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Further Reading
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
